Becker's Healthcare March 5, 2025
Four healthcare groups have filed an amicus brief in opposition to Johnson & Johnson’s 340B rebate model, arguing the policy undermines federal law and threatens safety-net hospitals.
The brief was submitted Feb. 28 by the American Hospital Association, the Children’s Hospital Association, the Association of American Medical Colleges and America’s Essential Hospitals with respect to a lawsuit before the U.S. District Court for the District of Columbia.
The 340B program requires drug manufacturers to provide discounts to hospitals that serve underserved populations. J&J’s rebate model, however, seeks to impose additional conditions on these discounts, potentially delaying or reducing financial relief for hospitals, the brief...